Both in Biotechnology
Liminatus Pharma vs Tessera Defense and Homeland Security
Over the past year LIMN returned −19.5% and HLSQ returned −88.7%; their daily moves had a correlation of 0.19.
LIMN −19.5% HLSQ −88.7%Growth of $1, one year, split-adjusted
| Metric | LIMN | HLSQ |
|---|---|---|
| Price | $2.79 | $0.1440 |
| Market cap | $3.8M | $3.0M |
| Today | +0.16% | −1.57% |
| 1 month | −24.5% | −53.6% |
| 6 months | −72.7% | — |
| Year to date | −90.8% | — |
| 1 year | −95.8% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | — |
| Dividend yield | — | — |
| Volatility (60d) | 1,152.5% | — |
| Short % of float | 4.6% | 3.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).